As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
Researchers have identified a blood signature that can predict lung cancer risk years before diagnosis – significant findings that could enhance ...
Survival outcomes in non-small cell lung cancer: Real-world analysis of immunotherapy era vs pre-immunotherapy era, with insights into treatment settings, racial disparities, and socioeconomic impacts ...
Please provide your email address to receive an email when new articles are posted on . Machine learning models can predict which patients receiving lung cancer therapy may need urgent care visits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results